168 related articles for article (PubMed ID: 32368009)
21. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
Li P; Liu Y; He Q
Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
[TBL] [Abstract][Full Text] [Related]
22. Facile preparation of biocompatible nanostructured lipid carrier with ultra-small size as a tumor-penetration delivery system.
Zhao X; Tang D; Yang T; Wang C
Colloids Surf B Biointerfaces; 2018 Oct; 170():355-363. PubMed ID: 29940502
[TBL] [Abstract][Full Text] [Related]
23. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
Hui F; Qin X; Zhang Q; Li R; Liu M; Ren T; Zhao M; Zhao Q
Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
[TBL] [Abstract][Full Text] [Related]
24. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
25. [Study on porous maize starch preparation and powdering coix seed oil].
Jiang YR; Zhang ZH; Ding DM; Sun E; Wang J; Jia XB
Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(14):2287-91. PubMed ID: 24199556
[TBL] [Abstract][Full Text] [Related]
26. Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity.
Lages EB; Fernandes RS; Silva JO; de Souza ÂM; Cassali GD; de Barros ALB; Miranda Ferreira LA
Biomed Pharmacother; 2020 Dec; 132():110876. PubMed ID: 33113428
[TBL] [Abstract][Full Text] [Related]
27. pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release.
Xiong H; Wu Y; Jiang Z; Zhou J; Yang M; Yao J
J Colloid Interface Sci; 2019 Feb; 536():135-148. PubMed ID: 30366179
[TBL] [Abstract][Full Text] [Related]
28. Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.
Li T; Lv M; Chen X; Yu Y; Zang G; Tang Z
Drug Des Devel Ther; 2019; 13():1289-1300. PubMed ID: 31118568
[No Abstract] [Full Text] [Related]
29. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial Activity of Nanostructured Lipid Carriers Loaded
Fathi N; Lotfipour F; Dizaj SM; Hamishehkar H; Mohammadi M
Pharm Nanotechnol; 2020; 8(6):485-494. PubMed ID: 33407060
[TBL] [Abstract][Full Text] [Related]
31. A cytotoxic nitrido-osmium(VI) complex induces caspase-mediated apoptosis in HepG2 cancer cells.
Huang WQ; Wang CX; Liu T; Li ZX; Pan C; Chen YZ; Lian X; Man WL; Ni WX
Dalton Trans; 2020 Dec; 49(47):17173-17182. PubMed ID: 33119012
[TBL] [Abstract][Full Text] [Related]
32. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug.
Chinsriwongkul A; Chareanputtakhun P; Ngawhirunpat T; Rojanarata T; Sila-on W; Ruktanonchai U; Opanasopit P
AAPS PharmSciTech; 2012 Mar; 13(1):150-8. PubMed ID: 22167418
[TBL] [Abstract][Full Text] [Related]
33. Design, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydration.
Tichota DM; Silva AC; Sousa Lobo JM; Amaral MH
Int J Nanomedicine; 2014; 9():3855-64. PubMed ID: 25143733
[TBL] [Abstract][Full Text] [Related]
34. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.
Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL
Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661
[TBL] [Abstract][Full Text] [Related]
35. Preparation of novel butyryl galactose ester-modified coix component microemulsions and evaluation on hepatoma-targeting in vitro and in vivo.
Liu MJ; Qu D; Chen Y; Liu CY; Liu YP; Ding XF
Drug Deliv; 2016 Nov; 23(9):3444-3451. PubMed ID: 27198659
[TBL] [Abstract][Full Text] [Related]
36. Ketoprofen-loaded pomegranate seed oil nanoemulsion stabilized by pullulan: Selective antiglioma formulation for intravenous administration.
Ferreira LM; Cervi VF; Gehrcke M; da Silveira EF; Azambuja JH; Braganhol E; Sari MH; Zborowski VA; Nogueira CW; Cruz L
Colloids Surf B Biointerfaces; 2015 Jun; 130():272-7. PubMed ID: 25935266
[TBL] [Abstract][Full Text] [Related]
37. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
38. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice.
Zhang XY; Qiao H; Ni JM; Shi YB; Qiang Y
Eur J Pharm Sci; 2013 Jun; 49(3):411-22. PubMed ID: 23624327
[TBL] [Abstract][Full Text] [Related]
39. A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy.
Li SS; Zhang CM; Wu JD; Liu C; Liu ZP
Eur J Med Chem; 2022 Jan; 228():114037. PubMed ID: 34883290
[TBL] [Abstract][Full Text] [Related]
40. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma.
Wang Y; Liu Y; Liu Y; Zhou W; Wang H; Wan G; Sun D; Zhang N; Wang Y
Int J Pharm; 2015 Apr; 483(1-2):89-100. PubMed ID: 25681730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
